BioSpace News Archive

LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced a new companion diagnostic called therascreen® PIK3CA PCR mutation analysis, which is now available through LabCorp and its Integrated Oncology specialty laboratory.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action has been filed on behalf of investors who purchased or otherwise acquired the securities of Indivior plc between March 10, 2015 and April 9, 2019, inclusive.

Randomized controlled trials (RCTs), commonly referred to as A/B tests, have long been the gold standard for scientific evidence in medicine and are increasingly used in other fields as diverse as education, government policy, and poverty reduction

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time (5:00pm Pacific Time) following data presentations at the 79th Scientific Sessions of the American Diabetes Association on its t:slim X2 with Control-IQ technology system.

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the four proposals considered and voted upon by its stockholders at its Annual Meeting on June 6, 2019.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will release its financial results for the fourth quarter and fiscal year ended March 31, 2019 after financial markets close on June 20, 2019.

Audentes Therapeutics, Inc. announced it has granted equity awards on June 5, 2019, that were previously approved by the Compensation Committee of its Board of Directors under the Audentes Therapeutics, Inc. 2018 Equity Inducement Plan, as a material inducement to employment to nine individuals hired by Audentes from April 25 through May 31, 2019.

Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) are today presenting research that shows higher levels of advanced glycation end products (AGEs), found in abundance in junk food, are associated with food allergy in children.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Pfizer Inc. (NYSE: PFE).

The guidance tends to focus on getting sponsor companies to include more historically underserved populations in clinical trials, including women, the elderly and minorities.